Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023

SELL
$15.0 - $22.76 $10,920 - $16,569
-728 Reduced 0.25%
294,726 $4.85 Million
Q4 2022

Feb 10, 2023

SELL
$14.16 - $24.02 $144,035 - $244,331
-10,172 Reduced 3.33%
295,454 $4.41 Million
Q3 2022

Nov 10, 2022

BUY
$18.07 - $31.37 $31,044 - $53,893
1,718 Added 0.57%
305,626 $6.84 Million
Q2 2022

Aug 12, 2022

SELL
$13.31 - $34.88 $1,943 - $5,092
-146 Reduced 0.05%
303,908 $5.09 Million
Q1 2022

May 13, 2022

BUY
$20.26 - $32.36 $6.16 Million - $9.84 Million
304,054 New
304,054 $9.1 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $577M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.